stars 1 stars 2 stars 3

NangioTx is a pharmaceutical company developing peptide-drug formulations for blood-vessel regeneration. Blood-vessel formation induced by our patent-pending V-10 peptide restores blood flow, promotes tissue regeneration and saves limbs in models of peripheral artery disease.

NangioTx Questions

The NangioTx annual revenue was $7 million in 2026.

NangioTx is based in Newark, New Jersey.

The NAICS codes for NangioTx are [54171, 541, 54, 541714, 5417].

The SIC codes for NangioTx are [87, 873].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users